HEADER ANTIMICROBIAL PROTEIN 01-AUG-15 2N5W TITLE THE NMR SOLUTION STRUCTURE OF OCTYL-TRIDECAPTIN A1 IN DPC MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: OCTYL-TRIDECAPTIN A1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: FMOC-SPPS SYNTHESIS KEYWDS TRIDECAPTIN A1, LIPOPEPTIDE, ANTIMICROBIAL, ANTIBIOTIC, NON- KEYWDS 2 RIBOSOMAL, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.A.COCHRANE,B.FINDLAY,A.BAKHTIARY,J.Z.ACEDO,E.M.RODRIGUEZ-LOPEZ, AUTHOR 2 J.C.VEDERAS REVDAT 3 26-OCT-16 2N5W 1 JRNL REVDAT 2 19-OCT-16 2N5W 1 JRNL REVDAT 1 28-SEP-16 2N5W 0 JRNL AUTH S.A.COCHRANE,B.FINDLAY,A.BAKHTIARY,J.Z.ACEDO, JRNL AUTH 2 E.M.RODRIGUEZ-LOPEZ,P.MERCIER,J.C.VEDERAS JRNL TITL ANTIMICROBIAL LIPOPEPTIDE TRIDECAPTIN A1 SELECTIVELY BINDS JRNL TITL 2 TO GRAM-NEGATIVE LIPID II. JRNL REF PROC.NATL.ACAD.SCI.USA V. 113 11561 2016 JRNL REFN ISSN 0027-8424 JRNL PMID 27688760 JRNL DOI 10.1073/PNAS.1608623113 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT P. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N5W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-AUG-15. REMARK 100 THE RCSB ID CODE IS RCSB104461. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : 6 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 180 MM DPC, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 4FO A 2 -163.42 -67.95 REMARK 500 1 TRP A 5 -72.82 -89.46 REMARK 500 1 DAB A 7 -171.06 68.59 REMARK 500 1 4FO A 8 175.72 -56.46 REMARK 500 2 4FO A 2 -150.78 -69.04 REMARK 500 2 TRP A 5 -72.77 -89.48 REMARK 500 2 DAB A 7 179.52 66.99 REMARK 500 2 4FO A 8 -178.04 -62.85 REMARK 500 3 4FO A 2 -114.73 -68.89 REMARK 500 3 TRP A 5 -72.88 -89.67 REMARK 500 3 DAB A 7 -175.97 54.05 REMARK 500 3 4FO A 8 -165.83 -64.20 REMARK 500 3 28J A 12 -31.77 95.26 REMARK 500 4 4FO A 2 -145.04 -69.08 REMARK 500 4 TRP A 5 -72.86 -89.48 REMARK 500 5 4FO A 2 -144.98 -69.11 REMARK 500 5 TRP A 5 -72.84 -89.68 REMARK 500 5 DAB A 7 -174.91 53.64 REMARK 500 5 4FO A 8 179.66 -62.93 REMARK 500 5 GLU A 10 43.36 -108.04 REMARK 500 6 TRP A 5 -72.59 -89.34 REMARK 500 6 DAB A 7 -50.71 -178.20 REMARK 500 7 4FO A 2 -145.64 -69.06 REMARK 500 7 SER A 4 93.72 56.72 REMARK 500 7 TRP A 5 -72.65 -87.44 REMARK 500 7 DAB A 7 -45.15 -171.37 REMARK 500 7 GLU A 10 26.50 -140.84 REMARK 500 8 4FO A 2 -167.86 -63.08 REMARK 500 8 SER A 4 94.96 58.32 REMARK 500 8 TRP A 5 -72.74 -90.96 REMARK 500 8 DAB A 7 -39.88 -178.18 REMARK 500 9 4FO A 2 -145.35 -69.03 REMARK 500 9 TRP A 5 -72.70 -89.63 REMARK 500 9 DAB A 7 175.49 57.52 REMARK 500 9 4FO A 8 -176.07 52.74 REMARK 500 10 4FO A 2 173.45 172.31 REMARK 500 10 SER A 4 -174.36 -64.49 REMARK 500 10 TRP A 5 -72.76 -89.39 REMARK 500 10 SER A 6 -172.18 -64.77 REMARK 500 10 DAB A 7 152.33 -47.72 REMARK 500 11 4FO A 2 178.54 178.18 REMARK 500 11 SER A 4 109.09 -177.76 REMARK 500 11 TRP A 5 -72.59 -93.20 REMARK 500 11 DAB A 7 37.32 -178.36 REMARK 500 12 4FO A 2 -160.95 -66.93 REMARK 500 12 TRP A 5 -72.37 -86.69 REMARK 500 12 SER A 6 179.25 -55.19 REMARK 500 12 4FO A 8 176.02 -56.25 REMARK 500 13 4FO A 2 -166.27 -63.53 REMARK 500 13 SER A 4 -169.95 -71.01 REMARK 500 REMARK 500 THIS ENTRY HAS 79 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25737 RELATED DB: BMRB DBREF 2N5W A 1 13 PDB 2N5W 2N5W 1 13 SEQRES 1 A 13 4N3 4FO GLY SER TRP SER DAB 4FO PHE GLU VAL 28J ALA MODRES 2N5W DAB A 7 ALA 2,4-DIAMINOBUTYRIC ACID HET 4N3 A 1 40 HET 4FO A 2 16 HET DAB A 7 16 HET 4FO A 8 16 HET 28J A 12 19 HETNAM 4N3 N-OCTANOYL-D-VALINE HETNAM 4FO (2R)-2,4-DIAMINOBUTANOIC ACID HETNAM DAB 2,4-DIAMINOBUTYRIC ACID HETNAM 28J D-ALLOISOLEUCINE FORMUL 1 4N3 C13 H25 N O3 FORMUL 1 4FO 2(C4 H10 N2 O2) FORMUL 1 DAB C4 H10 N2 O2 FORMUL 1 28J C6 H13 N O2 LINK C 4N3 A 1 N 4FO A 2 1555 1555 1.36 LINK C 4FO A 2 N GLY A 3 1555 1555 1.33 LINK C SER A 6 N DAB A 7 1555 1555 1.36 LINK C DAB A 7 N 4FO A 8 1555 1555 1.36 LINK C 4FO A 8 N PHE A 9 1555 1555 1.33 LINK C VAL A 11 N 28J A 12 1555 1555 1.36 LINK C 28J A 12 N ALA A 13 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 135 0 5 0 0 0 0 6 0 0 0 1 END